D01145 | |
D number | D01145 |
Classification | Drug |
Name | Azelnidipine (JP17/INN); Azelnidipine tablets (JP17); Calblock (TN) |
Component | - |
Formula | C33H34N4O6 |
Exact mass | 582.2478 |
Mol weight | 582.6463 |
Structural formula | ![]() |
Sequence | - |
Sequence type | - |
Source | - |
Upper DGroup | Cardiovascular agent DG01928 Dihydropyridine calcium channel blocker Other DG01575 Calcium channel blocker DG01496 Calcium channel L type blocker Cyp substrate DG01633 CYP3A substrate |
Remark | Therapeutic category: 2149 |
Activity | - |
Disease | - |
Comment | Dihydropyridine derivative |
Target | CACNA1C [HSA:775] [KO:K04850]; CACNA1D [HSA:776] [KO:K04851]; CACNA1F [HSA:778] [KO:K04853]; CACNA1S [HSA:779] [KO:K04857] |
Metabolism | Enzyme: CYP3A4 [HSA:1576] |
Interaction | Transporter inhibition: ABCB1 [HSA:5243] |
Other DBs | CAS: 123524-52-7 PubChem: 7848208 ChEBI: 31247 ChEMBL: CHEMBL1275868 LigandBox: D01145 NIKKAJI: J429.875F |
KCF data | - |